Agenus to Provide Corporate Update and First Quarter 2021 Financial Report
Conference Call on Thursday, May 6, 2021 at 8:30 a.m. ETLEXINGTON, Mass., April 22, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ:…
Pharmaceuticals, Biotechnology and Life Sciences
Conference Call on Thursday, May 6, 2021 at 8:30 a.m. ETLEXINGTON, Mass., April 22, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ:…
REDWOOD CITY, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that…
SAN FRANCISCO, April 22, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…
LEXINGTON, Mass., April 22, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,…
VANCOUVER, British Columbia, April 22, 2021 (GLOBE NEWSWIRE) — Segra International Corp, a Canadian agriculture technology company and a global…
Q1 2021 revenue Gradual improvement in activity: Reported revenue of €176.3 million, impacted by a significant currency effect-3.0% at constant exchange…
PRESS RELEASE April 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that…
Updated results will be presented from ASPEN-01, the ongoing Phase 1b Study of ALX148 in combination trastuzumab, ramucirumab and paclitaxel in…
PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirementsRALEIGH, N.C., April…
COPENHAGEN, Denmark, April 21, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative…